Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Goldsmith

Showing results (31-40 of 79) with videos related to

Pageof 8
Sort By:
The American Journal of Physiology|August 1, 1987
Alterations in protein transport events in rat liver after estrogen treatmentM A Goldsmith, A L Jones, B J Underdown, et al.
Current Biology : CB|February 28, 1998
Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylationK D Liu, S L Gaffen, M A Goldsmith, et al.
The Journal of Biological Chemistry|September 22, 1995
Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transductionK D Liu, S Y Lai, M A Goldsmith, et al.
Journal of Virology|April 25, 2000
Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) virusesS Y Chan, R F Speck, M C Ma, et al.
Cancer Clinical Trials|January 1, 1980
Phase I study of m-AMSA in patients with solid tumors and leukemiasM A Goldsmith, S Bhardwaj, T Ohnuma, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 1999
CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissueM L Penn, J C Grivel, B Schramm, et al.
Cancer|February 1, 1983
Phase I study of L-alanosine (NSC 15353)M A Goldsmith, T Ohnuma, M Spigelman, et al.
American Journal of Clinical Oncology|October 1, 1984
Phase I study of mitoxantrone on a daily X 5 scheduleM A Goldsmith, T Ohnuma, I H Jaffrey, et al.
The Journal of Biological Chemistry|May 16, 1998
Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosisJ H Bauer, K D Liu, Y You, et al.
The Journal of Biological Chemistry|May 20, 1994
The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elementsM A Goldsmith, W Xu, M C Amaral, et al.
Pageof 8

Showing results (31-40 of 79) with videos related to

Sort By:
Pageof 8
The American Journal of Physiology|August 1, 1987
Alterations in protein transport events in rat liver after estrogen treatmentM A Goldsmith, A L Jones, B J Underdown, et al.
Current Biology : CB|February 28, 1998
Janus kinases in interleukin-2-mediated signaling: JAK1 and JAK3 are differentially regulated by tyrosine phosphorylationK D Liu, S L Gaffen, M A Goldsmith, et al.
The Journal of Biological Chemistry|September 22, 1995
Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transductionK D Liu, S Y Lai, M A Goldsmith, et al.
Journal of Virology|April 25, 2000
Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) virusesS Y Chan, R F Speck, M C Ma, et al.
Cancer Clinical Trials|January 1, 1980
Phase I study of m-AMSA in patients with solid tumors and leukemiasM A Goldsmith, S Bhardwaj, T Ohnuma, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 20, 1999
CXCR4 utilization is sufficient to trigger CD4+ T cell depletion in HIV-1-infected human lymphoid tissueM L Penn, J C Grivel, B Schramm, et al.
Cancer|February 1, 1983
Phase I study of L-alanosine (NSC 15353)M A Goldsmith, T Ohnuma, M Spigelman, et al.
American Journal of Clinical Oncology|October 1, 1984
Phase I study of mitoxantrone on a daily X 5 scheduleM A Goldsmith, T Ohnuma, I H Jaffrey, et al.
The Journal of Biological Chemistry|May 16, 1998
Heteromerization of the gammac chain with the interleukin-9 receptor alpha subunit leads to STAT activation and prevention of apoptosisJ H Bauer, K D Liu, Y You, et al.
The Journal of Biological Chemistry|May 20, 1994
The cytoplasmic domain of the interleukin-2 receptor beta chain contains both unique and functionally redundant signal transduction elementsM A Goldsmith, W Xu, M C Amaral, et al.
Pageof 8